^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CD19/CD22 dual-target CAR-T

    i
    Other names: CD19/CD22 dual-target CAR-T
    Associations
    News
    Trials
    Company:
    Shenzhen University General Hospital
    Drug class:
    CD19-targeted CAR-T immunotherapy, CD22-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials